Nanosystems for Brain Targeting of Antipsychotic Drugs: An Update on the Most Promising Nanocarriers for Increased Bioavailability and Therapeutic Efficacy

Orally administered antipsychotic drugs are the first-line treatment for psychotic disorders, such as schizophrenia and bipolar disorder. Nevertheless, adverse drug reactions jeopardize clinical outcomes, resulting in patient non-compliance. The design formulation strategies for enhancing brain drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferreira, Maria Daniela, Duarte, Joana, Veiga, Francisco, Paiva-Santos, Ana Cláudia, Pires, Patrícia C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959474/
https://www.ncbi.nlm.nih.gov/pubmed/36840000
http://dx.doi.org/10.3390/pharmaceutics15020678

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959474/
https://www.ncbi.nlm.nih.gov/pubmed/36840000
http://dx.doi.org/10.3390/pharmaceutics15020678

Ejemplares similares